IP Verse

Improved Hvt-Vectored Nd-Ibd Vaccine - EP3185899

The patent EP3185899 was granted to Intervet on Oct 18, 2017. The application was originally filed on Dec 23, 2015 under application number EP15817860A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3185899

INTERVET
Application Number
EP15817860A
Filing Date
Dec 23, 2015
Status
Granted And Under Opposition
Sep 15, 2017
Grant Date
Oct 18, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM ANIMAL HEALTH USAJul 16, 2018D YOUNGADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP0719864
INTERNATIONAL-SEARCH-REPORTUS2014147457
INTERNATIONAL-SEARCH-REPORTWO2013057235
OPPOSITIONEP0719864
OPPOSITIONEP1026246
OPPOSITIONUS2014147457
OPPOSITIONUS5980906
OPPOSITIONUS6045803
OPPOSITIONWO2013057235
OPPOSITIONWO2013057236
OPPOSITIONWO2013144355

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- ARMOUR et al., "Current and Future Applications of Viral-VectoredRecombinant Vaccines in Poultry", Poultry Informed Professional, (20140000), vol. 134, pages 1 - 12, XP055514571
OPPOSITION- CUI et al., "Avirulent Marek's Disease Virus Type 1 Strain 814 Vectored Vaccine Expressing Avian Influenza (Al) Virus HS Haemagglutinin Induced Better Protection Than Turkey Herpesvirus Vectored Al Vaccine", PLoS ONE, (20130000), vol. 8, no. 1, pages e53340-1 - e53340-9, XP055462419
OPPOSITION- DARTEIL et al., "Herpesvirus of Turkey Recombinant Viruses Expressing Infectious Bursal Disease Virus (IBDV) VP2 lmmunogen Induce Protection against an IBDV Virulent Challenge in Chickens", Virology, (19950820), vol. 211, no. 2, pages 481 - 490, XP055514564
OPPOSITION- SCHAT, "Back to the past: do vector vaccines represent the future?", Barn Health, (20150505), URL: http://www.barnhealth.com/wp-content/uploads/2016/01/Vector_Vaccines_Dr.-Schat.pdf, XP055514694
OPPOSITION- WOO et al., "Gene clustering pattern, promoter architecture, and gene expression stability in eukaryotic genomes", PNAS, (20110222), vol. 108, no. 8, pages 3306 - 3311, XP055514530
OPPOSITION- THORNTON et al., "Efficacy of Marek's disease vaccines: Protection and Viraemia studies with turkey herpes virus vaccines", Avian Pathology, (19750400), vol. 4, no. 2, pages 97 - 108, XP055514532
OPPOSITION- TSUKAMOTO et al., "Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens", Journal of Virology, (20020600), vol. 76, no. 11, pages 5637 - 5645, XP002967899
OPPOSITION- GAO et al., "Expression of HA of HPAI HSN1 Virus at US2 Gene Insertion Site of Turkey Herpesvirus Induced Better Protection than That at US 10 Gene Insertion Site", PLoS ONE, (20110700), vol. 6, no. 7, pages e22549-1 - e22549-9, XP055462416

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents